Attenuating Ischemia Reperfusion Injury After Living Donor Renal Transplantation
Status:
Withdrawn
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
Patients undergoing living donor renal transplant will be asked to participate to determine
whether pre-operative dosing of immunosuppressive medication, and the donor organ receiving
an additional dose of antibody induction therapy helps to alleviate potential damage to the
transplanted organ post-transplant. A number of lab tests will be done post-transplant to
determine how well the kidney is functioning.